Osteoporosis International

, Volume 15, Issue 3, pp 175–179 | Cite as

Fracture risk following an osteoporotic fracture

  • O. Johnell
  • J. A. Kanis
  • A. Odén
  • I. Sernbo
  • I. Redlund-Johnell
  • C. Petterson
  • C. De Laet
  • B. Jönsson
Original Article


The aim of this study was to examine the pattern of fracture risk following a prior fracture at the spine, shoulder or hip. We studied 1918 patients with fractures at these sites identified from the Department of Radiology in Malmo who were followed for 5 years. Poisson regression was used to compute fracture rates immediately after the initial fracture and at 5 years thereafter in men and women aged 60 or 80 years. Immediate fracture risk was higher than that of the general population, more markedly so at the age of 60 than at 80 years. At the age of 60 years, the risk of hip, forearm and spine fractures were significantly increased following a prior spine, hip or shoulder fracture in men. A similar pattern was seen in women, except that the increase in risk of forearm fracture following a spine or hip fracture was not statistically significant. The incidence of further fractures at the shoulder, spine or hip fell with time after the first fracture, a fall that was significant for all fractures after a shoulder fracture, hip fracture after a spine fracture, and hip and spine fractures after a hip fracture. We conclude that the risk of a subsequent fracture immediately after an osteoporotic fracture is highest immediately after the event. This provides a rationale for very early intervention immediately after fractures to avoid recurrent fractures.


Fracture risk Forearm Hip Osteoporosis Spine 



We are grateful for the unrestricted support of the Alliance for Better Bone Health, Lilly, Hologic, IGEA, G-E Lunar, Wyeth, Roche and Novartis. These studies were supported by the International Osteoporosis Foundation, the National Osteoporosis Foundation and the International Society for Clinical Densitometry.


  1. 1.
    Klotzbuecher CM, Ross PD, Landsman PB, Abbot III TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedGoogle Scholar
  2. 2.
    Johnell O, Odén A, Caulin F, Kanis JA (2001) Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int 12:207–214CrossRefPubMedGoogle Scholar
  3. 3.
    Lindsay R, Silverman SL, Cooper C, Hanley DA; Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk for new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedGoogle Scholar
  4. 4.
    Kanis JA, Johnell O, Odén A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jönsson B (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674CrossRefPubMedGoogle Scholar
  5. 5.
    Jonsson B, Gardsell P, Johnell O, Redlund-Johnell I, Sernbo I (1994) Remembering fractures: fracture registration and proband recall in Southern Sweden. J Epidemiol Comm Health 48:489–490Google Scholar
  6. 6.
    Van Staa TP, Leufkens HGM, Coopewr C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624–629CrossRefGoogle Scholar
  7. 7.
    Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O (2003) Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10 year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14:61–68PubMedGoogle Scholar
  8. 8.
    Castel H, Bonneth DY, Sherf M, Liel Y (2001) Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low impact fractures. Osteoporos Int 12:559–564CrossRefPubMedGoogle Scholar
  9. 9.
    Torgerson DJ, Dolan P (1998) Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 57:378–379PubMedGoogle Scholar
  10. 10.
    Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracture. Lancet 348:1535–1541PubMedGoogle Scholar
  11. 11.
    Cummings SR, Black DM, Thompson DE et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 280:2077–2082PubMedGoogle Scholar
  12. 12.
    Harris ST, Watts NB, Genant HK et al. for the VERT Study Group (1999)Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA 282:1344–1352PubMedGoogle Scholar
  13. 13.
    Reginster J-Y, Minne HW, Sörensen OH et al. (2000) on behalf of the VERT Study Group. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83–91PubMedGoogle Scholar
  14. 14.
    McClung MR, Geusens P, Miller PD et al. (2001) for the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340CrossRefPubMedGoogle Scholar
  15. 15.
    Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene; results from a 3-year randomized clinical trail. Multiple Outcome of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645PubMedGoogle Scholar
  16. 16.
    Neer RM, Arnaud CD, Zanchetta JR et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  • O. Johnell
    • 1
  • J. A. Kanis
    • 2
  • A. Odén
    • 3
  • I. Sernbo
    • 1
  • I. Redlund-Johnell
    • 1
  • C. Petterson
    • 1
  • C. De Laet
    • 4
  • B. Jönsson
    • 5
  1. 1.Department of OrthopaedicsMalmö University HospitalMalmöSweden
  2. 2.WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical SchoolSheffieldUK
  3. 3.GothenburgSweden
  4. 4.Institute for Public HealthUniversity Medical CenterRotterdamThe Netherlands
  5. 5.Department of EconomicsStockholm School of EconomicsStockholmSweden

Personalised recommendations